News Archive

PETERSBURG—Governor Ralph Northam today announced that AMPAC Fine Chemicals (AFC), a leading manufacturer of Active Pharmaceutical Ingredients (APIs) in the United States, will invest $25 million to expand its existing operation on North Normandy Drive in the City of Petersburg. Virginia successfully competed with California and Texas for the project, which will create 156 new jobs. Governor Northam joined company leaders, key partners, and local economic development officials at AMPAC’s Petersburg facility to make the announcement.

Barrier function of epithelia is crucial for maintaining homeostasis in the human body. Its disruption in organs such as the intestine, kidney, lung, skin, eye, or the blood– brain-barrier is a hallmark of numerous diseases and toxic effects.1–3 Studying epithelial barrier function is essential for understanding disease processes, development of new therapeutic treatments, and investigation of compound safety. Permeability of epithelia grown in vitro is therefore routinely evaluated by fundamental and pharmaceutical researchers alike. In addition, proper barrier function is an important prerequisite when studying transport phenomena across epithelia in vitro.

Image: https://pubs.rsc.org

Johnson & Johnson Innovation – JLABS @ Washington, DC: We did it! Persevering through a time of great challenge and change, today we’re happy to share that we’ve opened our doors in a thriving ecosystem, to entrepreneurs, early-stage companies and the life sciences community.

BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using super-computational methods to target allosteric binding sites and guide enzymes back to their proper shape, today announced new pre-clinical data from its GBA1 Parkinson’s disease program. The findings were highlighted in a presentation at the XXVI International Association of Parkinsonism and Related Disorders (IAPRD) World Congress, a research conference dedicated to Parkinson’s disease and other disorders affecting muscle tone and motor control, being held virtually May 1-4, 2021.

Women Building Bio 2021 is just around the corner.

Save the date for September 30th to join our 6th year of Women Building Bio. An event always focused on advancing the bioscience through collaboration between industry and academia, researchers and innovators, professionals and decision-makers.

On a first-quarter earnings call Thursday, Emergent’s CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company.

Image: https://www.bizjournals.com

Locally Researched by: Carolyn M. Proctor, Washington Business Journal Apr 30, 2021, 6:00am EDT

Source: The companies, Form 990s, SEC filings and regional economic development agencies

Around Baltimore, folks tend to analyze economic trends through three vantage points: the city, the region and the state. No matter which level you’re looking at, data on venture capital shows that the first quarter of 2021 brought an influx of investment for local emerging companies.

Data from the latest MoneyTree report by PwC/CB Insights shows that Maryland companies received a collective $562 million in investment over 24 deals. It was a nearly 68% increase in the number of dollars and a 26% increase in the number of deals from the fourth quarter of 2020, which capped off a big year of investment in the pandemic.

Image: nsightin Health’s team in the South Baltimore office. (Courtesy photo)

A potential vaccine has brought new life to the embattled Gaithersburg biotech.

Image: Novavax CEO Stanley Erck, left, and Gregory Glenn, head of research and development, at Novavax’s office in Gaithersburg. EMAN MOHAMMED